(Q34557787)

3 August 2017

title

Bioinformatics analysis reveals potential candidate drugs for HCC. (English)

1 reference

3 August 2017

1 reference

Xiao-Bing Huang

1

1 reference

3 August 2017

Jing Li

2

1 reference

3 August 2017

Lu Zheng

3

1 reference

3 August 2017

Guo-Hua Zuo

4

1 reference

3 August 2017

Ke-Qiang Han

5

1 reference

3 August 2017

Hong-Yan Li

6

1 reference

3 August 2017

Ping Liang

7

1 reference

3 August 2017

publication date

23 January 2013

1 reference

Pathology Oncology Research

3 August 2017

published in

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

251-258

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-012-9576-y

3 August 2017

exact match

0 references

cites work

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Cirrhosis and the aetiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Controlling the false discovery rate in behavior genetics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Signaling pathways in cancer and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Clinical development of histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9576-Y

Hepatocellular carcinoma in Italian patients with cirrhosis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Gene expression analysis in burn wounds of rats

1 reference

12 December 2020

Long-term prognosis in hepatocellular carcinoma patients after hepatectomy.

1 reference

12 December 2020

Genetic variation in the Fat10 gene is associated with risk of hepatocellular carcinoma in a Chinese population.

1 reference

12 December 2020

10.1007/S12253-012-9576-Y

Identifiers

DOI

1 reference

release_lue6luznizcgtiueou4edmwp3m

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lue6luznizcgtiueou4edmwp3m

24 November 2022

mapped directly with Wikidata item

1 reference